StartupsFinSMEsabout 2 hours ago
Xellar Biosystems Raises $50M in Series A and A+ Financing
1 min read
Xellar Biosystems closed $50 million in combined Series A and A+ financing. The funding round supports the company's development of organ-on-a-chip technology for drug discovery and toxicity testing. The financing will accelerate platform commercialization and expand research partnerships.
Level
Hype check
Tap to vote and see what everyone thinks.